SCHEMBL320995

SCHEMBL320995

O=C(O)C1=CCNc2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 1/20 0.35
ALDH1A1 P00352 4/20 0.34
MAPT P10636 4/20 0.34
PTPRC P08575 2/20 0.34
LMNA P02545 2/20 0.34
DAO P14920 1/20 0.33
TSHR P16473 1/20 0.33
NAPRT Q6XQN6 1/20 0.33
ALOX15 P16050 1/20 0.33
GAA P10253 1/20 0.33
PIM1 P11309 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
SRD5A2 P31213 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
LIG1 P18858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30440575 1.00 NOS2 (0.35) NOS2ALDH1A1MAPTPTPRCLMNA
SCHEMBL1052801 0.98 NOS2 (0.34) NOS2ALDH1A1MAPTPTPRCLMNA
Hydrochloric Acid SCHEMBL1768618 0.98 NOS2 (0.34) NOS2ALDH1A1MAPTPTPRCLMNA
Hydrochloric Acid SCHEMBL6271322 0.98 NOS2 (0.34) NOS2ALDH1A1MAPTPTPRCLMNA
Hydrochloric Acid SCHEMBL27972450 0.96 NOS2 (0.33) NOS2ALDH1A1MAPTPTPRCLMNA
SCHEMBL28031614 0.90 ALDH1A1 (0.33) ALDH1A1MAPTPTPRCLMNAMEN1
SCHEMBL30239049 0.85 NOS2 (0.37) NOS2ALDH1A1MAPTLMNATSHR
Hydrochloric Acid SCHEMBL6671312 0.84 NOS2 (0.36) NOS2ALDH1A1MAPTTSHRMEN1
SCHEMBL27460826 0.82 ALDH1A1 (0.37) NOS2ALDH1A1MAPTLMNARAB9A
SCHEMBL14829873 0.82 NOS2 (0.32) NOS2MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107427507-B Therapeutic agent for respiratory infection 杏林制药株式会社 2021-12-17 CN claimed
WO-2020065668-A1 CRYSTALLINE FORM OF OZENOXACIN AND PROCESSES FOR PREPARATION THEREOF MAITHRI DRUGS PVT LTD (IN) 2020-04-02 WO claimed
CN-107522718-B A kind of synthetic method of Marbofloxacin 浙江国邦药业有限公司 2019-11-08 CN claimed
WO-2017060779-A1 INDUSTRIAL PROCESS FOR MAKING AN IVACAFTOR AND ITS INTERMEDIATES OPTIMUS DRUGS (P) LIMITED (IN) 2017-04-13 WO claimed
CN-105801482-A Method for preparing 1-cyclopropyl-4-oxo-7-bromine-8-difluoromethoxy-1,4-dihydro-quinoline-3-nonanoic acid-ethyl ester 浙江中欣氟材股份有限公司 2016-07-27 CN claimed
CN-105777631-A Synthesizing method of 1-cyclopropyl-4-oxo-7-bromo-8-difluoromethoxy-1,4-dihydro-quinoline-3-carboxylic acid ethyl ester 浙江中欣氟材股份有限公司 2016-07-20 CN claimed
EP-3003289-A1 OXAZOLIDINONE-QUINOLONE HYBRID ANTIBACTERIALS FOR THE PARENTERAL TREATMENT OR PROPHYLAXIS OF BACTERIAL DISEASES Morphochem Aktiengesellschaft Für Kombinatorische Chemie (DE) 2016-04-13 EP claimed
EP-3003307-A1 COMBINATION THERAPY COMPRISING OXAZOLIDINONE-QUINOLONES FOR USE IN TREATING BACTERIAL INFECTIONS Morphochem Aktiengesellschaft Für Kombinatorische Chemie (DE) 2016-04-13 EP claimed
CN-103819401-B The synthetic method of the fluoro-8-methoxyl group-Isosorbide-5-Nitrae-dihydroquinoline-3-carboxylic acid of 1-cyclopropyl-4-oxo-7- ZHEJIANG ZHONGXIN FLUORINE MATERIALS CO., LTD. (CN) 2016-04-13 CN claimed
CN-103930414-B Crystal of 7- { (3S,4S) -3- [ (cyclopropylamino) methyl ] -4-fluoropyrrolidin-1-yl } -6-fluoro-1- (2-fluoroethyl) -8-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid KYORIN PHARMACEUTICAL CO.,LTD. (JP) 2016-01-20 CN claimed
CN-1157389-C Quinoline carboxylic acid derivative or salt thereof ������ҩ��ʽ���� 2004-07-14 CN claimed
EP-1401834-A1 NEW DERIVATIVES OF OXAZOLIDINONES AS ANTIBACTERIAL AGENTS LABORATORIOS VITA, S.A. (ES) 2004-03-31 EP claimed
WO-2003086402-A1 ANHYDROUS CRYSTALLINE FORMS I AND II OF 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-(3-METHYL-1-PIPERAZINYL) 4-OXO-l, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID (GATIFLOXACIN) DR. REDDY'S LABORATORIES LIMITED (IN) 2003-10-23 WO claimed
WO-2003084475-A2 INHIBITORS OF THE S100-p53 PROTEIN-PROTEIN INTERACTION AND METHOD OF INHIBITING CANCER EMPLOYING THE SAME UNIVERSITY OF MARYLAND, BALTIMORE (US) 2003-10-16 WO claimed
WO-2003002560-A1 NEW DERIVATIVES OF OXAZOLIDINONES AS ANTIBACTERIAL AGENTS LABORATORIOS VITA, S.A. (ES) 2003-01-09 WO claimed
EP-1230235-A1 COMPOUNDS WITH ANTIBACTERIAL AND ANTIPARASITIC PROPERTIES New Pharma Research Sweden AB (SE) 2002-08-14 EP claimed
CN-1358183-A Quinolinecarboxylic acid derivative or salts thereof WAKUZAGA PHARMACEUTICAL CO LTD (JP) 2002-07-10 CN claimed
WO-2001036408-A1 COMPOUNDS WITH ANTIBACTERIAL AND ANTIPARASITIC PROPERTIES NEW PHARMA RESEARCH SWEDEN AB (SE) 2001-05-25 WO claimed
CN-1057297-C Crystals of antimicrobial compound DAIICHI SEIYAKU CO (JP) 2000-10-11 CN claimed
CN-1106006-A Crystals of antimicrobial compound DAIICHI SEIYAKU CO (JP) 1995-08-02 CN claimed